Pharma in Europe: Going from Heartburn to Heart Attack? — AME...
Popularity Report
 |
|||
|
|||
|
|||
|
|||
|
|||
|
Rank
URL Tag Cloud
Bookmark History
Saved by 1 people (0 private), first by anonymouse user on 2007-03-21
- Jmresearch on 2007-03-21 - Tags europe , industry , pharmaceutical , stats
Public Sticky notes
France was once a true leader in pharmaceutical R&D, but the nation of Pasteur “has seen its contribution of new drug launches fall from around 50 in 1985-89 to just 12 in 1990-94.” Since 1994, the picture for pharmaceutical innovation in France has not improved much and the French government finally took note: in 2004, it began seeking advice on ways to make France more receptive for bio-tech investment.
Highlighted by jmresearch
The European pharmaceutical industry is moving its research and development activities almost wholesale from continental Europe to the United States. Though most Europeans seem unperturbed, the shift has been momentous: “in 1990, the . . . pharmaceutical industry still invested 50% more in Europe than in the US . . . today, the same industry is investing 40% more in the US compared to Europe.”
Highlighted by jmresearch
Public Comment